Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced its financial results for the third quarter ending September 30, 2024. “Our third-quarter results came ...

英为财情Investing.com - Akoya Biosciences (NASDAQ: AKYA )星期四发布了第三季度的财报，数据显示，公司营收逊于分析师的预期，每股收益低于分析师的预期。 在该公司发布的最新财报中，公司每股收益为$-0.210，总营收为$18.8M，而此前英为财情Investing.com对分析师的调查显示，分析师预期该公司的营收为$25.43M，每股收益为$-0.200 ...

Akoya Biosciences (AKYA) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to loss of $0.26 per share a year ago. These figures ...

The life sciences sector often encounters complex risks that require specialized insurance solutions and deep industry expertise. Skyward Specialty's Life Sciences liability coverage delivers a ...

MARLBOROUGH, Mass. (AP) — MARLBOROUGH, Mass. (AP) — Akoya Biosciences Inc. (AKYA) on Thursday reported a loss of $10.5 million in its third quarter. On a per-share basis, the Marlborough, ...

Tarsus Pharmaceuticals, Inc. (TARS) came out with a quarterly loss of $0.61 per share versus the Zacks Consensus Estimate of a loss of $0.90. This compares to loss of $1.28 per share a year ago. These ...

The global environmental test equipment market is projected to be valued at USD 1.2 billion in 2023, with a growth rate of ...

Nov. 05, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company ®, will unveil innovations designed to accelerate insights in immuno-oncology (IO) and ...

Akoya Biosciences (NASDAQ:AKYA – Get Free Report) will announce its earnings results after the market closes on Thursday, ...

In a report released today, William Bonello from Craig-Hallum maintained a Buy rating on Akoya Biosciences (AKYA – Research Report). The ...